EI
BIIB icon

Ellevest Inc’s Biogen BIIB Stock Holding History

Ellevest Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$723K Sell
3,946
-1,221
-24% -$225K 0.1% 147
2025
Q4 		$909K Buy
5,167
+272
+6% +$44.4K 0.13% 115
2025
Q3 		$686K Buy
4,895
+3,244
+196% +$438K 0.1% 151
2025
Q2 		$207K Buy
+1,651
New +$206K 0.03% 369
2023
Q2 		– Sell
-286
Closed -$79.5K – 516
2023
Q1 		$79.5K Sell
286
-1,051
-79% -$291K 0.01% 499
2022
Q4 		$370K Buy
1,337
+664
+99% +$188K 0.03% 187
2022
Q3 		$180K Buy
673
+642
+2,071% +$136K 0.02% 293
2022
Q2 		$6K Buy
31
+1
+3% +$204 ﹤0.01% 968
2022
Q1 		$6K Sell
30
-5
-14% -$1.09K ﹤0.01% 970
2021
Q4 		$8K Sell
35
-558
-94% -$143K ﹤0.01% 891
2021
Q3 		$168K Buy
593
+33
+6% +$10.8K 0.02% 304
2021
Q2 		$194K Sell
560
-61
-10% -$18.5K 0.02% 266
2021
Q1 		$174K Buy
621
+19
+3% +$5.12K 0.02% 250
2020
Q4 		$147K Buy
602
+577
+2,308% +$149K 0.02% 232
2020
Q3 		$7K Sell
25
-183
-88% -$51K ﹤0.01% 700
2020
Q2 		$56K Buy
208
+10
+5% +$3.01K 0.01% 345
2020
Q1 		$63K Buy
198
+82
+71% +$24.9K 0.02% 193
2019
Q4 		$34K Buy
116
+111
+2,220% +$30.8K 0.01% 279
2019
Q3 		$1K Buy
+5
New +$1.16K ﹤0.01% 365

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ellevest Inc's BIIB Position: Q1 2026 in Review

Ellevest Inc reduced its Biogen (BIIB) stake by 24% in Q1 2026, selling an estimated $225K and leaving 3,946 shares worth $723K. The position accounts for 0.1% of the portfolio, ranked #147.

Ellevest Inc first reported a position in BIIB in Q3 2019 and has held it in 19 quarters since. The position peaked at $909K in Q4 2025. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Ellevest Inc held 3,946 shares of Biogen worth $723K as of Q1 2026.
  • Ellevest Inc sold 1,221 Biogen shares in Q1 2026, an estimated $225K.
  • Biogen made up 0.1% of Ellevest Inc's portfolio in Q1 2026, its #147 holding.
  • Ellevest Inc first reported a position in Biogen in Q3 2019 and has held it in 19 quarters since.
  • Ellevest Inc's Biogen position peaked at $909K in Q4 2025.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.